Recently, the results of the "RZ U45" China's Best Young Investment Figures selection, hosted by RZ Media and RZ Research, were grandly announced. Zhu Pai, CEO of Efung Capital, stood out among numerous candidates with his profound industry insight and successfully made the list.

The "RZ U45" is an authoritative selection in China's equity investment industry initiated by RZ Media and RZ Research, aiming to identify outstanding young investment leaders under the age of 45 who have demonstrated exceptional performance in China's equity investment sector. The selection comprehensively evaluates candidates based on multiple dimensions, including personal track record, institutional and team management scale, investment capabilities, and project exit performance. The final winners list is determined through in-depth research and data assessment.

As a leading media platform for China's equity investment and industrial investment, RZ Media has long focused on reporting on the development of China's new economy and the full chain of innovation investment. Its selection results carry broad influence and authority within the industry. The release of the "U45" list is not only a recognition of the professional capabilities of the individual winners but also a collective showcase of the power of China's young investment professionals — they are becoming the backbone of China's venture capital industry with a proactive and enterprising attitude.

Looking ahead, Efung Capital will continue to focus on long-term value, act as true "patient capital," build a solid bridge between technology and industry, and help Chinese innovative pharmaceutical companies navigate the "last mile" from the laboratory to the market. On this track that requires long-term commitment, Efung Capital will join hands with all young Chinese investors, responding to the call of the times with vision and responsibility — together, we will write a new chapter for China's venture capital and healthcare industry in this era of innovation and endeavor.